Candidate genes for proliferative diabetic retinopathy

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Petrovič, Daniel ^a,b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b Zavod Srce   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN I; ANGIOTENSINOGEN; CELL ADHESION MOLECULE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRINOGEN; FIBROBLAST GROWTH FACTOR 2; GLUTATHIONE TRANSFERASE; GROWTH HORMONE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTEGRIN; INTERLEUKIN DERIVATIVE; MANGANESE SUPEROXIDE DISMUTASE; MATRIX METALLOPROTEINASE; MYELOPEROXIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; POLYOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RENIN; SOMATOMEDIN; TUMOR NECROSIS FACTOR; VASCULOTROPIN; VITAMIN D; CYTOKINE;

BLOOD VESSEL PERMEABILITY; DIABETIC RETINOPATHY; DISEASE COURSE; DNA POLYMORPHISM; EPIGENETICS; FIBROSIS; GENE; HEMOCHROMATOSIS; HUMAN; IRON METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOGENESIS; PROTEOMICS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETICS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; RISK FACTOR;

CYTOKINES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; GENETIC ASSOCIATION STUDIES; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84884269048     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/540416     Document Type: Review

References (78)

1. Klein R., Klein B. E. K., Harris C. I., Cowie C. C., Stern M. P., Boyko E. J., Reiber G. E., Bennett P. H., Visual disorders in diabetes: diabetes in America. Report of National Institutes of Diabetes and Digestive and Kidney Diseases 1995 Bethesda, Md, USA National Institutes of Health 293 338
2. Brownlee M., The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005 54 6 1615 1625 2-s2.0-20044376702 10.2337/diabetes.54. 6.1615
3. Reddy M. A., Natarajan R., Epigenetic mechanisms in diabetic vascular complications. Cardiovascular Research 2011 90 3 421 429 2-s2.0-79957487252 10.1093/cvr/cvr024
4. Zhong Q., Kowluru R. A., Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon. Journal of Cellular Biochemistry 2010 110 6 1306 1313 2-s2.0-77955498700 10.1002/jcb.22644
5. Uhlmann K., Kovacs P., Boettcher Y., Hammes H.-P., Paschke R., Genetics of diabetic retinopathy. Experimental and Clinical Endocrinology and Diabetes 2006 114 6 275 294 2-s2.0-33746765731 10.1055/s-2006-924260
6. Petrovič M. G., Hawlina M., Peterlin B., Petrovič D., BglII gene polymorphism of the α 2 β 1 integrin gene is a risk factor for diabetic retinopathy in Caucasians with type 2 diabetes. Journal of Human Genetics 2003 48 9 457 460 2-s2.0-0142021848 10.1007/s10038-003-0060-0
7. Nikolajevic-Starčević J., Petrovic M. G., Petrovic D., A1/A2 polymorphism of the glycoproteinb IIIa gene and diabetic retinopathy in Caucasians with type 2 diabetes. Clinical and Experimental Ophthalmology 2011 39 665 672
8. Engerman R. L., Kern T. S., Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 1987 36 7 808 812 2-s2.0-0023641117
9. Porta M., Sjoelie A.-K., Chaturvedi N., Stevens L., Rottiers R., Veglio M., Fuller J. H., Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study. Diabetologia 2001 44 12 2203 2209 2-s2.0-0035668758 10.1007/s001250100030
10. Hallman D. M., Huber J. C., Gonzalez V. H., Klein B. E. K., Klein R., Hanis C. L., Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas. Diabetes Care 2005 28 5 1163 1168 2-s2.0-18144384717 10.2337/diacare.28.5.1163
11. Rema M., Saravanan G., Deepa R., Mohan V., Familial clustering of diabetic retinopathy in South Indian type 2 diabetic patients. Diabetic Medicine 2002 19 11 910 916 2-s2.0-0036434422 10.1046/j.1464-5491.2002.00820.x
12. Warpeha K. M., Chakravarthy U., Molecular genetics of microvascular disease in diabetic retinopathy. Eye 2003 17 3 305 311 2-s2.0-0037617928 10.1038/sj.eye.6700348
13. Balasubbu S., Rajendran A., Ramasamy K., Namperumalsamy P., Sundaresan P., Emerging patterns of possible potential candidate gene polymorphisms associated with diabetic retinopathy-a. Asian Journal of Experimental Sciences 2006 20 15 28
14. Ng D. P. K., Human genetics of diabetic retinopathy: current perspectives. Journal of Ophthalmology 2010 2010 6 172593 10.1155/2010/172593
15. Patel S., Chen H., Tinkham N. H., Zhang K., Genetic susceptibility of diabetic retinopathy. Current Diabetes Reports 2008 8 4 257 262 2-s2.0-52649133999 10.1007/s11892-008-0046-6
16. Petrovič M. G., Korošec P., Košnik M., Osredkar J., Hawlina M., Peterlin B., Petrovič D., Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy. Molecular Vision 2008 14 1382 1387 2-s2.0-48749083021
17. Petrovič M. G., Krkovič M., Osredkar J., Hawlina M., Petrovič D., Polymorphisms in the promoter region of the basic fibroblast growth factor gene and proliferative diabetic retinopathy in Caucasians with type 2 diabetes. Clinical and Experimental Ophthalmology 2008 36 2 168 172 2-s2.0-41249088219 10.1111/j.1442-9071.2007.01647.x
18. Petrovič M. G., Osredkar J., Saraga-babić M., Petrovič D., K469E polymorphism of the intracellular adhesion molecule 1 gene is associated with proliferative diabetic retinopathy in Caucasians with type 2 diabetes. Clinical and Experimental Ophthalmology 2008 36 5 468 472 2-s2.0-50849113053 10.1111/j.1442-9071.2008.01785.x
19. Cilenšek I., Mankoč S., Globočnik Petrovič M., Petrovič D., The 4a/4a genotype of the VNTR polymorphism for endothelial nitric oxide synthase (eNOS) gene predicts risk for proliferative diabetic retinopathy in Slovenian patients (Caucasians) with type 2 diabetes mellitus. Molecular Biology Reports 2012 39 6 7061 7067
20. Doganay S., Evereklioglu C., Er H., Türköz Y., Sevinç A., Mehmet N., Şavli H., Comparison of serum NO, TNF- α IL-1 β sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye 2002 16 2 163 170 2-s2.0-0035984887 10.1038/sj.EYE. 6700095
21. Abu El-Asrar A. M., Struyf S., Opdenakker G., van Damme J., Geboes K., Expression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes. Molecular Vision 2010 16 1098 1107 2-s2.0-77955647882
22. Kunicki T. J., Kritzik M., Annis D. S., Nugent D. J., Hereditary variation in platelet integrin α 2 β 1 density is associated with two silent polymorphisms in the α 2 gene coding sequence. Blood 1997 89 6 1939 1943 2-s2.0-0030942489
23. McLeod D. S., Lefer D. J., Merges C., Lutty G. A., Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. American Journal of Pathology 1995 147 3 642 653 2-s2.0-0029162588
24. Abu El-Asrar A. M., Nawaz M. I., Kangave D., Siddiquei M. M., Geboes K., Osteopontin and other regulators of angiogenesis and fibrogenesis in the vitreous from patients with proliferative vitreoretinal disorders. Mediators of Inflammation 2012 2012 8 493043 10.1155/2012/493043
25. van Beijnum J. R., Buurman W. A., Griffioen A. W., Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 2008 11 1 91 99 2-s2.0-41049117932 10.1007/s10456-008-9093-5
26. Wang G. L., Semenza G. L., General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proceedings of the National Academy of Sciences of the United States of America 1993 90 9 4304 4308 2-s2.0-0027210562
27. Abu El-Asrar A. M., Nawaz M. I., Kangave D., Abouammoh M., Mohammad G., High-mobility group box-1 and endothelial cell angiogenic markers in the vitreous from patients with proliferative diabetic retinopathy. Mediators of Inflammation 2012 2012 7 697489 10.1155/2012/697489
28. Simó R., Carrasco E., García-Ramírez M., Hernández C., Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Current Diabetes Reviews 2006 2 1 71 98
29. Petrovič M. G., Korošec P., Košnik M., Hawlina M., Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy. American Journal of Ophthalmology 2007 143 1 175 176 2-s2.0-33845508850 10.1016/j.ajo.2006.07.032
30. Hernández C., Fonollosa A., García-Ramírez M., Higuera M., Catalán R., Miralles A., García-Arumí J., Simó R., Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema. Diabetes Care 2006 29 9 2028 2033
31. Abu El-Asrar A. M., Struyf S., Kangave D., Geboes K., van Damme J., Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. European Cytokine Network 2006 17 3 155 165 2-s2.0-39049193307
32. Murata M., Noda K., Fukuhara J., Kanda A., Kase S., Saito W., Ozawa Y., Mochizuki S., Kimura S., Mashima Y., Okada Y., Ishida S., Soluble vascular adhesion protein-1 accumulates in proliferative diabetic retinopathy. Investigative Ophthalmology and Visual Science 2012 53 7 4055 4062
33. Anagnostou A., Lee E. S., Kessimian N., Levinson R., Steiner M., Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 1990 87 15 5978 5982 2-s2.0-0025297296 10.1073/pnas.87.15.5978
34. García-Ramírez M., Hernández C., Simó R., Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects. Diabetes Care 2008 31 6 1189 1194 2-s2.0-48649089571 10.2337/dc07-2075
35. McVicar C. M., Hamilton R., Colhoun L. M., Gardiner T. A., Brines M., Cerami A., Stitt A. W., Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy. Diabetes 2011 60 11 2995 3005 2-s2.0-80755152818 10.2337/db11-0026
36. Mitola S., Belleri M., Urbinati C., Coltrini D., Sparatore B., Pedrazzi M., Melloni E., Presta M., Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. Journal of Immunology 2006 176 1 12 15 2-s2.0-29644441337
37. Castonguay R., Werner E. D., Matthews R. G., Presman E., Mulivor A. W., Solban N., Sako D., Pearsall R. S., Underwood K. W., Seehra J., Kumar R., Grinberg A. V., Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth. The Journal of Biological Chemistry 2011 286 34 30034 30046 2-s2.0-80051920312 10.1074/jbc.M111.260133
38. Yoshida S., Ishikawa K., Matsumoto T., Yoshida A., Ishibashi T., Kono T., Reduced concentrations of angiogenesis-related factors in vitreous after vitrectomy in patients with proliferative diabetic retinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology 2010 248 6 799 804 2-s2.0-77952097817 10.1007/s00417-010-1301-5
39. Yoshida S., Nakama T., Ishikawa K., Arima M., Tachibana T., Nakao S., Sassa Y., Yasuda M., Enaida H., Oshima Y., Kono T., Ishibashi T., Antiangiogenic shift in vitreous after vitrectomy in patients with proliferative diabetic retinopathy. Investigative Ophthalmology and Visual Science 2012 53 11 6997 7003
40. Khalfaoui T., Lizard G., Beltaief O., Colin D., Ben Hamida J., Errais K., Ammous I., Zbiba W., Tounsi L., Zhioua R., Anane R., Ouertani-Meddeb A., Immunohistochemical analysis of cellular adhesion molecules (ICAM-1, VCAM-1) and VEGF in fibrovascular membranes of patients with proliferative diabetic retinopathy: preliminary study. Pathologie Biologie 2009 57 7-8 513 517 2-s2.0-71849083307 10.1016/j.patbio.2008.07.021
41. Awata T., Inoue K., Kurihara S., Ohkubo T., Watanabe M., Inukai K., Inoue I., Katayama S., A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002 51 5 1635 1639 2-s2.0-0036316846
42. Beránek M., Kanková K., Benes P., Izakovicová- Hollá L., Znojil V., Hájek D., Vlková E., Vácha J., Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy. American Journal of Medical Genetics 2002 109 4 278 283
43. Ray D., Mishra M., Ralph S., Read I., Davies R., Brenchley P., Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 2004 53 3 861 864 2-s2.0-1442349965 10.2337/diabetes.53.3.861
44. Beranek M., Kolar P., Tschoplova S., Kankova K., Vasku A., Genetic variation and plasma level of the basic fibroblast growth factor in proliferative diabetic retinopathy. Diabetes Research and Clinical Practice 2008 79 2 362 367 2-s2.0-38349139190 10.1016/j.diabres.2007.09.012
45. Kim H. W., Ko G. J., Kang Y. S., Lee M. H., Song H. K., Kim H. K., Cha D. R., Role of the VEGF 936 C/T polymorphism in diabetic microvascular complications in type 2 diabetic patients. Nephrology 2009 14 7 681 688 2-s2.0-70349751398 10.1111/j.1440-1797.2009.01085.x
46. Abhary S., Burdon K. P., Gupta A., Lake S., Selva D., Petrovsky N., Craig J. E., Common sequence variation in the VEGFA gene predicts risk of diabetic retinopathy. Investigative Ophthalmology and Visual Science 2009 50 12 5552 5558 2-s2.0-73349129376 10.1167/iovs.09-3694
47. Nakamura S., Iwasaki N., Funatsu H., Kitano S., Iwamoto Y., Impact of variants in the VEGF gene on progression of proliferative diabetic retinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology 2009 247 1 21 26 2-s2.0-56949097632 10.1007/s00417-008-0915-3
48. Yang Y., Andresen B. T., Yang K., Zhang Y., Li X., Li X., Wang H., Association of vascular endothelial growth factor -634C/G polymorphism and diabetic retinopathy in type 2 diabetic Han Chinese. Experimental Biology and Medicine 2010 235 10 1204 1211 2-s2.0-77957824669 10.1258/ebm.2010.010102
49. Chun M., Hwang H., Cho H., Chun H., Woo J., Lee K., Nam M., Baik S., Kim Y., Park Y., Association of vascular endothelial growth factor polymorphisms with nonproliferative and proliferative diabetic retinopathy. Journal of Clinical Endocrinology and Metabolism 2010 95 7 3547 3551 2-s2.0-77954927699 10.1210/jc.2009-2719
50. Feghhi M., Nikzamir A., Esteghamati A., Mahmoudi T., Yekaninejad M. S., Relationship of vascular endothelial growth factor (VEGF) +405 G/C polymorphism and proliferative retinopathy in patients with type 2 diabetes. Translational Research 2011 158 2 85 91 2-s2.0-79960290076 10.1016/j.trsl.2011.03.002
51. Uthra S., Raman R., Mukesh B. N., Rajkumar S. A., Kumari R. P., Agarwal S., Paul P. G., Lakshmipathy P., Gnanamoorthy P., Sharma T., McCarty C. A., Kumaramanickavel G., Diabetic retinopathy and IGF-1 gene polymorphic cytosine-adenine repeats in a Southern Indian cohort. Ophthalmic Research 2007 39 5 294 299 2-s2.0-35048813608 10.1159/000108124
52. Szaflik J. P., Wysocki T., Kowalski M., Majsterek I., Borucka A. I., Blasiak J., Szaflik J., An association between vascular endothelial growth factor gene promoter polymorphisms and diabetic retinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology 2008 246 1 39 43 2-s2.0-36448980970 10.1007/s00417-007-0674-6
53. Crispim D., Fagundes N. J. R., Dos Santos K. G., Rheinheimer J., Bouças A. P., De Souza B. M., MacEdo G. S., Leiria L. B., Gross J. L., Canani L. H., Polymorphisms of the UCP2 gene are associated with proliferative diabetic retinopathy in patients with diabetes mellitus. Clinical Endocrinology 2010 72 5 612 619 2-s2.0-77950223717 10.1111/j.1365-2265.2009.03684.x
54. Zhao S., Li T., Zheng B., Zheng Z., Nitric oxide synthase 3 (NOS3) 4b/a, T-786C and G894T polymorphisms in association with diabetic retinopathy susceptibility: a meta-analysis. Ophthalmic Genetics 2012 33 4 200 207
55. Santos K. G., Crispim D., Canani L. H., Ferrugem P. T., Gross J. L., Roisenberg I., Relationship of endothelial nitric oxide synthase (eNOS) gene polymorphisms with diabetic retinopathy in Caucasians with type 2 diabetes. Ophthalmic Genetics 2012 33 1 23 27 2-s2.0-84856108524 10.3109/13816810.2011. 620057
56. Tong Z., Yang Z., Patel S., Chen H., Gibbs D., Yang X., Hau V. S., Kaminoh Y., Harmon J., Pearson E., Buehler J., Chen Y., Yu B., Tinkham N. H., Zabriskie N. A., Zeng J., Luo L., Sun J. K., Prakash M., Hamam R. N., Tonna S., Constantine R., Ronquillo C. C., Sadda S., Avery R. L., Brand J. M., London N., Anduze A. L., King G. L., Bernstein P. S., Watkins S., Ma X., Joshua-Cameron D., Rabena M., Goldfarb-Rumyantzev A., Banerjee N., Hilary-Keenan H., Mamalis N., Perez C., Katz B. J., Jorde L. B., Li D. Y., Aiello L. P., Pollak M. R., Zhang K., Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proceedings of the National Academy of Sciences of the United States of America 2008 105 19 6998 7003 2-s2.0-44349193611 10.1073/pnas.0800454105
57. Peterlin B., Petrovič M. G., Makuc J., Hawlina M., Petrovič D., A hemochromatosis-causing mutation C282Y is a risk factor for proliferative diabetic retinopathy in Caucasians with type 2 diabetes. Journal of Human Genetics 2003 48 12 646 649 2-s2.0-0346158239 10.1007/s10038-003-0094-3
58. Abhary S., Burdon K. P., Casson R. J., Goggin M., Petrovsky N. P., Craig J. E., Association between erythropoietin gene polymorphisms and diabetic retinopathy. Archives of Ophthalmology 2010 128 1 102 106 2-s2.0-75349097521 10.1001/archophthalmol.2009.355
59. Kanková K., Muzík J., Karásková J., Beránek M., Hájek D., Znojil V., Vlková E., Vácha J., Duration of non-Insulin-dependent diabetes mellitus and the TNF-beta NcoI genotype as predictive factors in proliferative diabetic retinopathy. Ophthalmologica 2001 215 4 294 298
60. Kumaramanickavel G., Sripriya S., Vellanki R. N., Upadyay N. K., Badrinath S. S., Arokiasamy T., Sukumar B., Vidhya A., Joseph B., Sharma T., Gopal L., Tumor necrosis factor allelic polymorphism with diabetic retinopathy in India. Diabetes Research and Clinical Practice 2001 54 2 89 94 2-s2.0-0034788783 10.1016/S0168-8227(01)00269-8
61. Yoshioka K., Yoshida T., Takakura Y., Umekawa T., Kogure A., Toda H., Yoshikawa T., Relationship between polymorphisms 804C/A and 252A/G of lymphotoxin- α gene and -308G/A of tumor necrosis factor α gene and diabetic retinopathy in Japanese patients with type 2 diabetes mellitus. Metabolism 2006 55 10 1406 1410 2-s2.0-33748444708
62. Paine S. K., Sen A., Choudhuri S., Mondal L. K., Chowdhury I. H., Basu A., Mukherjee A., Bhattacharya B., Association of tumor necrosis factor α interleukin 6, and interleukin 10 promoter polymorphism with proliferative diabetic retinopathy in type 2 diabetic subjects. Retina 2012 32 6 1197 1203 2-s2.0-81355164598 10.1097/IAE.0b013e31822f55f3
63. Jeon H. J., Choi H. J., Park B. H., Lee Y. H., Oh T., Association of monocyte chemoattractant protein-1 (MCP-1) 2518A/G polymorphism with proliferative diabetic retinopathy in Korean type 2 diabetes. Yonsei Medical Journal 2013 54 3 621 625
64. Liu L., Yu Q., Wang H., Zhang S. X., Huang C., Chen X., Association of intercellular adhesion molecule 1 polymorphisms with retinopathy in Chinese patients with type 2 diabetes. Diabetic Medicine 2006 23 6 643 648 2-s2.0-33744831240 10.1111/j.1464-5491.2006.01884.x
65. Ikegishi Y., Tawata M., Aida K., Onaya T., Z-4 allele upstream of the aldose reductase gene is associated with proliferative retinopathy in Japanese patients with NIDDM, and elevated luciferase gene transcription in vitro. Life Sciences 1999 65 20 2061 2070 2-s2.0-0033536561 10.1016/S0024-3205(99)00329-X
66. dos Santos K. G., Canani L. H., Gross J. L., Tschiedel B., Souto K. E. P., Roisenberg I., The -106CC genotype of the aldose reductase gene is associated with an increased risk of proliferative diabetic retinopathy in Caucasian-Brazilians with type 2 diabetes. Molecular Genetics and Metabolism 2006 88 3 280 284 2-s2.0-33745483315 10.1016/j.ymgme.2006.02.002
67. Szaflik J. P., Majsterek I., Kowalski M., Rusin P., Sobczuk A., Borucka A. I., Szaflik J., Blasiak J., Association between sorbitol dehydrogenase gene polymorphisms and type 2 diabetic retinopathy. Experimental Eye Research 2008 86 4 647 652 2-s2.0-41049097649 10.1016/j.exer.2008.01.009
68. Tarnow L., Cambien F., Rossing P., Nielsen F. S., Hansen B. V., Lecerf L., Poirier O., Danilov S., Parving H.-H., Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995 44 5 489 494 2-s2.0-0029069163
69. Globoçnik-Petrovič M., Hawlina M., Peterlin B., Petrovič D., Insertion/deletion plasminogen activator inhibitor 1 and insertion/deletion angiotensin-converting enzyme gene polymorphisms in diabetic retinopathy in type 2 diabetes. Ophthalmologica 2003 217 3 219 224 2-s2.0-0345700295 10.1159/000068975
70. Zhou J., Yang J., Angiotensin-converting enzyme gene polymorphism is associated with proliferative diabetic retinopathy: a meta-analysis. Acta Diabetologica 2010 47 supplement 1 S187 S193 2-s2.0-78751577597 10.1007/s00592-009-0160-1
71. Lu Y., Ge Y., Hu Q., Shi Y., Xue C., Shi Y., Chen S., Huang Z., Association between angiotensin-converting enzyme gene polymorphism and diabetic retinopathy in the Chinese population. Journal of the Renin-Angiotensin- Aldosterone System 2012 13 2 289 295
72. Merchant M. L., Klein J. B., Proteomics and diabetic retinopathy. Clinics in Laboratory Medicine 2009 29 1 139 149 2-s2.0-64749084912 10.1016/j.cll.2009.01.008
73. Wang H., Feng L., Hu J., Xie C., Wang F., Differentiating vitreous proteomes in proliferative diabetic retinopathy using high-performance liquid chromatography coupled to tandem mass spectrometry. Experimental Eye Research 2013 108 110 119
74. Mohammad G., Siddiquei M. M., Othman A., Al-Shabrawey M., Abu El-Asrar A. M., High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina. Experimental Eye Research 2013 107 101 109
75. Gao B., Chen X., Timothy N., Aiello L. P., Feener E. P., Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy. Journal of Proteome Research 2008 7 6 2516 2525 2-s2.0-49849090387 10.1021/pr800112g
76. Angi M., Kalirai H., Coupland S. E., Damato B. E., Semeraro F., Romano M. R., Proteomic analyses of the vitreous humour. Mediators of Inflammation 2012 2012 7 148039 10.1155/2012/148039
77. Cundiff D. K., Nigg C. R., Diet and diabetic retinopathy: insights from the Diabetes Control and Complications Trial (DCCT). MedGenMed Medscape General Medicine 2005 7 1, article 3 2-s2.0-25144525610
78. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group, Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. Journal of the American Medical Association 2003 290 16 2159 2167 2-s2.0-0142087597 10.1001/jama.290.16. 2159